Replay available

Medtronic plc (MDT) Q1 2026 Earnings Call

Medtronic plc (NYSE: MDT) Q1 2026 earnings conference call, held 2025-08-19. Replay captured from the company's public earnings webcast.

Tue, August 19, 2025 at 8:00 AMendedReplay
Medtronic plc (MDT) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Ryan Weissfenning

Vice President and Head of Medtronic Investor Relations

Jeff Martha

Chairman and Chief Executive Officer

Thierry Piertone

Chief Financial Officer

Mike Manero

Group President, Surgical Robotics

Travis Steed

Analyst at Bank of America Securities

Larry Beagleson

Analyst at Wells Fargo Securities

Mike Kratke

Analyst at Leran Partners

Robbie Marcus

Analyst at J.P. Morgan

Matt Mixick

Analyst at Barclays

Anthony Petrone

Analyst at Mizuho

Josh Jennings

Analyst at TD Securities

Matt O'Brien

Analyst at Piper Sandler

Joanne Wench

Analyst at Citi

Replay transcript excerpt

Hello, everyone, and thanks for joining us today for our Fiscal 26 First Quarter Video Earnings webcast. I'm Ryan Weissfenning, Vice President and Head of Medtronic Investor Relations. Joining me here today are Jeff Martha, Chairman and Chief Executive Officer, and Thierry Piertone, Chief Financial Officer. Jeff and Thierry will provide comments on the results of our first quarter, which ended on July 25, 2025, and our outlook for the remainder of Fiscal Year 26. After our prepared remarks, we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour. Earlier this morning, we issued a press release discussing our results and containing several financial schedules. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com. During today's program, many of the statements we make may be considered forward-looking statements, and actual results may differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause our actual results to differ is contained in our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. Unless we say otherwise, all comparisons are on a year-over-year basis, and revenue comparisons are made on an organic basis, which excludes the impact of foreign currency and first quarter revenue in the current and prior year reported as other. References to sequential revenue changes compare to the fourth quarter of fiscal 25 and are made on an as-reported basis. All share references are on a revenue and year-over-year ba...

More from Medtronic Plc.